SALT LAKE CITY, May 18, 2011 /PRNewswire/ -- USANA Health
Sciences, Inc. (NYSE: USNA) today announced plans to expand into
Thailand in the fourth quarter of
2011. This will be USANA's 16th market in which independent
distributors sell USANA's high quality, science-based products.
(Logo:
http://photos.prnewswire.com/prnh/20110110/LA27593LOGO)
According to the World Federation of Direct Selling Associations
(WFDSA), Thailand is the world's
13th-largest country in terms of retail U.S. dollars generated from
direct selling and Asia's
5th-largest market for direct selling, with estimated sales of more
than $1.5 billion. USANA's entry into
Thailand will serve as an
important next step in the company's plan for international
growth.
Dave Wentz, USANA's Chief
Executive Officer, said "We're very excited about our choice to
enter the Thailand market, given
that Thailand is one of the top
markets in the world for businesses like USANA. We currently have
leaders and customers, with existing ties to this country, who are
confident that USANA will succeed in this growing market.
Perhaps most importantly, we are confident that we will be
able to expand into Thailand and
still maintain focus on our primary expansion objective, which is
growing USANA through BabyCare in China."
About USANA
USANA develops and manufactures high quality nutritional,
personal care, and weight management products that are sold
directly to Associates and Preferred Customers throughout
the United States, Canada, China, Australia, New
Zealand, Hong Kong,
Japan, Taiwan, South
Korea, Singapore,
Mexico, Malaysia, the
Philippines, the
Netherlands, and the United
Kingdom. More information on USANA can be found at
http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act. Our actual results could differ
materially from those projected in these forward-looking
statements, which involve a number of risks and uncertainties,
including global economic conditions generally, reliance upon our
network of independent Associates, the governmental regulation of
our products, manufacturing and marketing risks, adverse publicity
risks, and risks associated with our international expansion.
The contents of this release should be considered in
conjunction with the risk factors, warnings, and cautionary
statements that are contained in our most recent filings with the
Securities and Exchange Commission.
Investors Contact: Patrique Richards
Investor Relations
(801) 954-7961
investor.relations@us.usana.com
Media Contact: Dan Macuga
Vice President of Marketing & Public Relations
USANA Health Sciences, Inc.
(801) 954-7280
Dan.Macuga@us.usana.com
SOURCE USANA Health Sciences, Inc.